Efficacy of High-Dose Dexamethasone for Nausea and Vomiting in Cancer Patients
Author Information
Author(s): H.Y. Al-Idrissi, E.M. Ibrahim, K.A. Abdullah, W.A. Ababtain, H.A. Boukhary, H.M.K. Macaulay
Primary Institution: College of Medicine and Medical Sciences, King Faisal University, Dammam, Saudi Arabia.
Hypothesis
Is high-dose dexamethasone more effective than a combination of dexamethasone, metoclopramide, and diphenhydramine in managing chemotherapy-induced nausea and vomiting?
Conclusion
High-dose dexamethasone is effective for preventing nausea and vomiting in cancer patients, but the combination regimen caused more side effects.
Supporting Evidence
- 50% of patients experienced no nausea with high-dose dexamethasone.
- 57% of patients were protected from vomiting with high-dose dexamethasone.
- 28% of patients experienced no nausea with the combination treatment.
- 43% of patients were protected from vomiting with the combination treatment.
- 45% of patients had no side effects from high-dose dexamethasone compared to 24% from the combination treatment.
Takeaway
This study tested two treatments to help cancer patients who feel sick from their medicine. One treatment worked better but had fewer side effects.
Methodology
A double-blind, randomized, crossover study comparing high-dose dexamethasone with a combination of dexamethasone, metoclopramide, and diphenhydramine in cancer patients receiving chemotherapy.
Limitations
The study did not evaluate the antiemetic properties of diphenhydramine separately.
Participant Demographics
Patients with histologically confirmed cancer receiving inpatient chemotherapy for the first time, aged 14-70, with a performance status of 70% or more.
Statistical Information
P-Value
P=0.09 for nausea, P=0.24 for vomiting, P=0.001 for side effects.
Want to read the original?
Access the complete publication on the publisher's website